Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) has been assigned an average rating of “Hold” from the six analysts that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $42.25.
Several analysts have issued reports on TRUP shares. Weiss Ratings reissued a “sell (d+)” rating on shares of Trupanion in a report on Monday, June 1st. Cantor Fitzgerald cut their price target on Trupanion from $42.00 to $34.00 and set a “neutral” rating for the company in a report on Thursday, April 9th. Bank of America cut their price target on Trupanion from $63.00 to $59.00 and set a “buy” rating for the company in a report on Tuesday, April 14th. Finally, Stifel Nicolaus cut their price target on Trupanion from $35.00 to $31.00 and set a “hold” rating for the company in a report on Tuesday, March 31st.
Check Out Our Latest Analysis on TRUP
Trupanion Stock Performance
Trupanion (NASDAQ:TRUP – Get Free Report) last released its quarterly earnings results on Thursday, April 30th. The financial services provider reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.04. Trupanion had a return on equity of 6.87% and a net margin of 1.74%.The business had revenue of $384.05 million during the quarter, compared to analyst estimates of $379.77 million. During the same quarter in the previous year, the company posted ($0.03) earnings per share. Trupanion’s revenue for the quarter was up 12.3% on a year-over-year basis. Analysts forecast that Trupanion will post 0.53 EPS for the current year.
Insider Activity
In other news, COO John R. Gallagher sold 3,603 shares of the business’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $21.69, for a total value of $78,149.07. Following the transaction, the chief operating officer directly owned 33,065 shares in the company, valued at $717,179.85. The trade was a 9.83% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Steve Weinrauch sold 6,674 shares of the business’s stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $22.00, for a total value of $146,828.00. Following the completion of the transaction, the executive vice president owned 78,062 shares in the company, valued at $1,717,364. The trade was a 7.88% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 17,806 shares of company stock worth $395,508 over the last ninety days. Corporate insiders own 5.58% of the company’s stock.
Hedge Funds Weigh In On Trupanion
Large investors have recently made changes to their positions in the business. Kelleher Financial Advisors purchased a new position in shares of Trupanion in the third quarter valued at about $74,000. Kemnay Advisory Services Inc. purchased a new position in shares of Trupanion in the fourth quarter valued at about $64,000. Parallel Advisors LLC lifted its position in shares of Trupanion by 1,831.9% in the first quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock valued at $47,000 after acquiring an additional 1,722 shares in the last quarter. PNC Financial Services Group Inc. lifted its position in shares of Trupanion by 21.7% in the third quarter. PNC Financial Services Group Inc. now owns 2,678 shares of the financial services provider’s stock valued at $116,000 after acquiring an additional 478 shares in the last quarter. Finally, Advisory Services Network LLC purchased a new position in shares of Trupanion in the third quarter valued at about $160,000.
Trupanion Company Profile
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Recommended Stories
- Five stocks we like better than Trupanion
- 3 Retail Winners Using Cash Flow to Stay Ahead
- 3 Tech ETFs That Could Bounce Back After the AI Selloff
- 3 Penny Stocks Under $5 Backed by Real Revenue Growth
- 3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
